Поисковый запрос: (<.>S=АНТИПАРКИНСОНИЧЕСКИЕ СРЕДСТВА<.>) |
Общее количество найденных документов : 81
Показаны документы с 1 по 20
|
|
1.
| Allelix in pact with Hoechst-Roussel for psychiatric drug development // Emerg. Pharm., 1995. Vol. 4, N 3.-С.4
|
2.
| Allelix in pact with Hoechst-Roussel for psychiatric drug development // Emerg. Pharm., 1995. Vol. 4, N 3.-С.4
|
3.
| Amantadine sulphate in treating Parkinson's disease: Clinical effects, psychometric tests and serum concentrations // J. Neurol., 1989. Vol. 236, N 3.-С.153-156
|
4.
| Anatomic and disease specificity of NADH CoQ[1] reductase (complex I) deficiency in Parkinson's disease // J. Neurochem., 1990. Vol. 55, N 6.-С.2142-2145
|
5.
| Apomorphine in Parkinson's disease: A. reappraisal // New. Trends Clin. Neuropharmacol., 1989. Vol. 3, N 2.-С.95
|
6.
| Nomoto Application of the common marmoset to pharmacological studies // Nihon yakurigaku zasshi, 1995. Vol. 106, N 1.-С.11-18
|
7.
| Jain Naveen K. Brain drug delivery system bearing dopamine hydrochloride for effective management of Parkinsonism // Drug Dev. and Ind. Pharm., 1998. Vol. 24, N 7.-С.671-675
|
8.
| Cardiovascular reflexes in Parkinson's disease: long-term effects of levodopa treatment on de novo patients // Acta neurol. scand., 1990. Vol. 81, N 4.-С.346-348
|
9.
| Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone // Neuroscience, 2011. Vol. 181.-С.234-242
|
10.
| Clinical evaluation of a novel dopaminergic agonist, CQA 206-291, in Parkinsonian patients: a double blind placebo controlled study // Fundam. and Clin. Pharmacol., 1989. Vol. 3, N 5.-С.584
|
11.
| Combination of selegiline and controlled release levodopa in the treatment of fluctiations of clinical disability in parkinsonian patients // Acta neurol. scand. Suppl., 1989. Vol. 80, N 126.-С.127-137
|
12.
| Continuous dopaminergic stimulation for parkinson's disease: Facts and fancy // Funct. Neurol., 1988. Vol. 3, N 4.-С.413-427
|
13.
| Controlled-release levodopa/benserazide (madopar HBS): Clinical observations and levodopa and dopamine plasma concentrations in fluctuating parkinsonian patients // J. Neurol., 1990. Vol. 237, N 1.-С.24-28
|
14.
| Controlled-release levopoda/carbidopa (CR-4) in parkinsonian patients with severe response fluctuations: clinical and pharmacokinetic data // Eur. J. Clin. Pharmacol., 1989. Vol. 36, Suppl..-С.105
|
15.
| Tarczy M. Correlation of plasma levodopa levels and motor performance in parkinsonian patients with response fluctuations // New Trends Clin. Neuropharmacol., 1989. Vol. 3, N 3.-С.155
|
16.
| Defective concept formation in Parkinsonians is independent from mental deterioration // J. Neurol. Neurosurg. and Psychiat., 1989. Vol. 52, N 3.-С.334-332
|
17.
| Rabinowitz Joshua D. Delivery of compounds for the treatment of Parkinsons through an inhalation route
|
18.
| Rabinowitz Joshua D. Delivery of compounds for the treatment of Parkinsons through an inhalation route
|
19.
| Determinants of gait in the elderly Parkinsonian on maintenance levodopa/carbidopa therapy // Brit. J. Clin. Pharmacol., 1990. Vol. 30, N 1.-С.13-24
|
20.
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor II.: Agonist and antagonist properties at subtypes of dopamne-D[2]-like receptor and 'альфа'[1]/'альфа'[2]-adrenoceptor // J. Pharmacol. and Exp. Ther., 2002. Vol. 303, N 2.-С.805-814
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"